Alzheimer's Disease Progressively Reduces Visual Functional Network Connectivity
Overview
Authors
Affiliations
Background: Postmortem studies of brains with Alzheimer's disease (AD) not only find amyloid-beta (Aβ) and neurofibrillary tangles (NFT) in the visual cortex, but also reveal temporally sequential changes in AD pathology from higher-order association areas to lower-order areas and then primary visual area (V1) with disease progression.
Objective: This study investigated the effect of AD severity on visual functional network.
Methods: Eight severe AD (SAD) patients, 11 mild/moderate AD (MAD), and 26 healthy senior (HS) controls undertook a resting-state fMRI (rs-fMRI) and a task fMRI of viewing face photos. A resting-state visual functional connectivity (FC) network and a face-evoked visual-processing network were identified for each group.
Results: For the HS, the identified group-mean face-evoked visual-processing network in the ventral pathway started from V1 and ended within the fusiform gyrus. In contrast, the resting-state visual FC network was mainly confined within the visual cortex. AD disrupted these two functional networks in a similar severity dependent manner: the more severe the cognitive impairment, the greater reduction in network connectivity. For the face-evoked visual-processing network, MAD disrupted and reduced activation mainly in the higher-order visual association areas, with SAD further disrupting and reducing activation in the lower-order areas.
Conclusion: These findings provide a functional corollary to the canonical view of the temporally sequential advancement of AD pathology through visual cortical areas. The association of the disruption of functional networks, especially the face-evoked visual-processing network, with AD severity suggests a potential predictor or biomarker of AD progression.
Dark H, Shafer A, Cordon J, An Y, Lewis A, Moghekar A Neurology. 2025; 104(4):e210271.
PMID: 39889254 PMC: 11784718. DOI: 10.1212/WNL.0000000000210271.
Zhao B, Li T, Li Y, Fan Z, Xiong D, Wang X Imaging Neurosci (Camb). 2024; 1:1-23.
PMID: 38770197 PMC: 11105703. DOI: 10.1162/imag_a_00015.
Yan Y, Gao M, Geng Z, Wu Y, Xiao G, Wang L Geroscience. 2024; 46(5):4779-4792.
PMID: 38727873 PMC: 11336126. DOI: 10.1007/s11357-024-01181-5.
Bergamino M, Burke A, Sabbagh M, Caselli R, Baxter L, Stokes A Front Aging Neurosci. 2024; 16:1362613.
PMID: 38562990 PMC: 10982426. DOI: 10.3389/fnagi.2024.1362613.
Marefat H, Vahabi Z, Afzalian N, Khanbagi M, Karimi H, Ebrahiminia F J Alzheimers Dis Rep. 2023; 7(1):1133-1152.
PMID: 38025804 PMC: 10657719. DOI: 10.3233/ADR-230132.